KOVAČ, MD, PHD, Viljem; ZWITTER, Matjaz; STANIC, Karmen; RAJER, Mirjana; KERN, Izidor; VRANKAR, Martina; EDELBAHER, Natalija. Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations. Radiology and Oncology, [S. l.], v. 48, n. 4, 2014. Disponível em: https://radioloncol.com/index.php/ro/article/view/2233. Acesso em: 10 jun. 2026.